Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.
Kulkarni PS, Zaman K, Desai SA, Bharati S, Goswami DR, Sharmeen AT, Rana S, Haque W, Khandelwal A, Manney S, Tyagi P, Gairola S, Zade JK, Pisal SS, Dhere RM, Poonawalla CS, Lamberigts C, Parulekar V, Potey AV.
Kulkarni PS, et al. Among authors: goswami dr.
Lancet Infect Dis. 2025 Jun 9:S1473-3099(25)00215-4. doi: 10.1016/S1473-3099(25)00215-4. Online ahead of print.
Lancet Infect Dis. 2025.
PMID: 40505670